Evidence map›Paper›PMID 32240663›Full record

ArticleToxicology and applied pharmacology2020

Aldehyde dehydrogenase-2 activation decreases acetaminophen hepatotoxicity by prevention of mitochondrial depolarization.

Hereward J Wimborne, Jiangting Hu, Kenji Takemoto, Nga T Nguyen, Hartmut Jaeschke, John J Lemasters, Zhi Zhong

Open access · greenAbstract read
In one paragraph

Article in Toxicology and applied pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. [Study based on the acetaldehyde dehydrogenase 2 gene polymorphism and acetaminophen-induced liver injury].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2024
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Actually Seeing What Is Going on - Intravital Microscopy in Tissue Engineering.Frontiers in bioengineering and biotechnology · 2021
    Review
  17. Experimental and therapeutic medicine · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hereward J WimborneCenter for Cell Death, Injury & Regeneration, Medical University of South Carolina, Charleston, SC, United States of America; Department of Drug Discovery & Biomedical Sciences, Medical University of South Carolina, Charleston, SC, United States of America.
Jiangting HuCenter for Cell Death, Injury & Regeneration, Medical University of South Carolina, Charleston, SC, United States of America; Department of Drug Discovery & Biomedical Sciences, Medical University of South Carolina, Charleston, SC, United States of America.
Kenji TakemotoCenter for Cell Death, Injury & Regeneration, Medical University of South Carolina, Charleston, SC, United States of America; Department of Drug Discovery & Biomedical Sciences, Medical University of South Carolina, Charleston, SC, United States of America.
Nga T NguyenDepartment of Pharmacology, Toxicology, & Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.
Hartmut JaeschkeDepartment of Pharmacology, Toxicology, & Therapeutics, University of Kansas Medical Center, Kansas City, KS, United States of America.
John J LemastersCenter for Cell Death, Injury & Regeneration, Medical University of South Carolina, Charleston, SC, United States of America; Department of Drug Discovery & Biomedical Sciences, Medical University of South Carolina, Charleston, SC, United States of America; Department of Biochemistry & Molecular Biology, Medical University of South Carolina, Charleston, SC, United States of America; Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, United States of America. Electronic address: JJLemasters@musc.edu.
Zhi ZhongCenter for Cell Death, Injury & Regeneration, Medical University of South Carolina, Charleston, SC, United States of America; Department of Drug Discovery & Biomedical Sciences, Medical University of South Carolina, Charleston, SC, United States of America. Electronic address: zhong@musc.edu.
Medical University of South Carolina · USUniversity of Kansas Medical Center · US

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Jian Ouyang · 2009 to 2026
$42.7M
Proteomics CoreP30DK123704 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI DON C. ROCKEY · 2020 to 2026
$8.8M
Mitochondrial depolarization, mitophagy, and mitochondrial DAMPs in ALDR01AA025379 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI ZHI ZHONG · 2018 to 2026
$3.8M
Autophagy and Drug-Induced Liver InjuryR01DK102142 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI DING, WEN-XING, JAESCHKE, HARTMUT W. · 2014 to 2022
$2.7M
Mechanisms of I/R Injury to HepatocytesR01DK073336 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI LEMASTERS, JOHN J · 2007 to 2017
$2.5M
VDAC in Ethanol and Aldehyde-Induced Mitochondrial DysfunctionR01AA021191 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI LEMASTERS, JOHN J · 2014 to 2018
$1.7M
Training in Bioenergetics, Oxidative Stress and Metabolic SyndromeT32DK083262 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI LEMASTERS, JOHN J · 2009 to 2018
$1.5M
Confocal/Multiphoton Microscope UpgradeS10OD018113 · OD · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI LEMASTERS, JOHN J · 2015 to 2015
$570k
Aldehyde Dehydrogenase-2 as a Drug Target for Cholestatic Liver FibrosisF31DK108570 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI WIMBORNE, HEREWARD JOHN CLFFORD · 2015 to 2017
$79k
NCI NIH HHS P30 CA138313NIAAA NIH HHS R01 AA021191NIAAA NIH HHS R01 AA025379NIDDK NIH HHS F31 DK108570NIDDK NIH HHS P30 DK123704NIDDK NIH HHS R01 DK073336NIDDK NIH HHS R01 DK102142NIDDK NIH HHS T32 DK083262NIH HHS S10 OD018113
6 · The paper itself

Abstract

Oxidative stress contributes to acetaminophen (APAP) hepatotoxicity. Since lipid peroxidation produces reactive aldehydes, we investigated whether activation of mitochondrial aldehyde dehydrogenase-2 (ALDH2) with Alda-1 decreases liver injury after APAP. Male C57BL/6 mice fasted overnight received Alda-1 (20 mg/kg, i.p.) or vehicle 30 min before APAP (300 mg/kg, i.p.). Blood and livers were collected 2 or 24 h after APAP. Intravital multiphoton microscopy of rhodamine 123 (Rh123) and propidium iodide (PI) fluorescence was conducted 6 h after APAP administration to detect mitochondrial polarization status and cell death. 4-Hydroxynonenal protein adducts were present in 0.1% of tissue area without APAP treatment but increased to 7% 2 h after APAP treatment, which Alda-1 blunted to 1%. Serum alanine and aspartate aminotransferases increased to 7594 and 9768 U/L at 24 h respectively, which decreased ≥72% by Alda-1. Alda-1 also decreased centrilobular necrosis at 24 h after APAP from 47% of lobular areas to 21%. N-acetyl-p-benzoquinone imine protein adduct formation and c-Jun-N-terminal kinase phosphorylation increased after APAP as expected, but Alda-1 did not alter these changes. Without APAP, no mitochondrial depolarization was detected by intravital microscopy. At 6 h after APAP, 62% of tissue area showed depolarization, which decreased to 33.5% with Alda-1. Cell death as detected by PI labeling increased from 0 to 6.8 cells per 30× field 6 h after APAP, which decreased to 0.6 cells by Alda-1. In conclusion, aldehydes are important mediators of APAP hepatotoxicity. Accelerated aldehyde degradation by ALDH2 activation with Alda-1 decreases APAP hepatotoxicity by protection against mitochondrial dysfunction.

Indexed as

AcetaminophenAlanine TransaminaseAldehyde Dehydrogenase, MitochondrialAnalgesics, Non-NarcoticAnimalsAspartate AminotransferasesBenzamidesBenzodioxolesChemical and Drug Induced Liver InjuryEnzyme ActivationLiverMaleMiceMice, Inbred C57BLMicroscopy, Fluorescence, MultiphotonMitochondria, LiverAcetaminophenAlanine TransaminaseAldehyde Dehydrogenase, MitochondrialALDH2 protein, mouseAnalgesics, Non-NarcoticAspartate AminotransferasesBenzamidesBenzodioxolesN-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamideAcetaminophenAlda-1Aldehyde dehydrogenase-2AldehydesHepatotoxicityMitochondrial depolarization

Identifiers

PMID32240663
PMCPMC7716617
OpenAlexW3014331104

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.